ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MESP1
|
ENSG00000166823.5 | MESP1 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_116165754 | 8.12 |
ENST00000405348.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr7_+_116166331 | 7.38 |
ENST00000393468.1 ENST00000393467.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr2_-_175870085 | 6.72 |
ENST00000409156.3 |
CHN1 |
chimerin 1 |
chr11_+_86511569 | 5.49 |
ENST00000441050.1 |
PRSS23 |
protease, serine, 23 |
chr12_+_6309963 | 4.94 |
ENST00000382515.2 |
CD9 |
CD9 molecule |
chr4_+_169418195 | 4.94 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr1_-_95392635 | 4.77 |
ENST00000538964.1 ENST00000394202.4 ENST00000370206.4 |
CNN3 |
calponin 3, acidic |
chr1_-_85930823 | 4.16 |
ENST00000284031.8 ENST00000539042.1 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
chr3_+_49059038 | 3.96 |
ENST00000451378.2 |
NDUFAF3 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 |
chr3_-_134093275 | 3.89 |
ENST00000513145.1 ENST00000422605.2 |
AMOTL2 |
angiomotin like 2 |
chr19_+_41725088 | 3.83 |
ENST00000301178.4 |
AXL |
AXL receptor tyrosine kinase |
chr3_-_149688896 | 3.68 |
ENST00000239940.7 |
PFN2 |
profilin 2 |
chr2_-_175869936 | 3.65 |
ENST00000409900.3 |
CHN1 |
chimerin 1 |
chr9_-_139940608 | 3.47 |
ENST00000371601.4 |
NPDC1 |
neural proliferation, differentiation and control, 1 |
chr3_-_149688502 | 3.46 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr5_-_54281407 | 3.30 |
ENST00000381403.4 |
ESM1 |
endothelial cell-specific molecule 1 |
chr3_+_158787041 | 3.29 |
ENST00000471575.1 ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
chr1_-_209979375 | 3.22 |
ENST00000367021.3 |
IRF6 |
interferon regulatory factor 6 |
chr5_+_102201722 | 3.19 |
ENST00000274392.9 ENST00000455264.2 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr5_-_16936340 | 3.15 |
ENST00000507288.1 ENST00000513610.1 |
MYO10 |
myosin X |
chr10_-_33625154 | 3.15 |
ENST00000265371.4 |
NRP1 |
neuropilin 1 |
chr3_-_120170052 | 3.14 |
ENST00000295633.3 |
FSTL1 |
follistatin-like 1 |
chr21_+_30502806 | 3.13 |
ENST00000399928.1 ENST00000399926.1 |
MAP3K7CL |
MAP3K7 C-terminal like |
chr12_-_110318263 | 3.10 |
ENST00000318348.4 |
GLTP |
glycolipid transfer protein |
chr10_+_124134201 | 3.08 |
ENST00000368990.3 ENST00000368988.1 ENST00000368989.2 ENST00000463663.2 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
chr12_-_77272765 | 2.99 |
ENST00000547435.1 ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2 |
cysteine and glycine-rich protein 2 |
chr4_-_157892498 | 2.86 |
ENST00000502773.1 |
PDGFC |
platelet derived growth factor C |
chr8_+_22438009 | 2.85 |
ENST00000409417.1 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr12_+_6309517 | 2.83 |
ENST00000382519.4 ENST00000009180.4 |
CD9 |
CD9 molecule |
chr2_-_190044480 | 2.83 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chr5_+_102201509 | 2.83 |
ENST00000348126.2 ENST00000379787.4 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr3_-_149688655 | 2.78 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr19_+_16187085 | 2.78 |
ENST00000300933.4 |
TPM4 |
tropomyosin 4 |
chr12_-_110318226 | 2.78 |
ENST00000544393.1 |
GLTP |
glycolipid transfer protein |
chr12_-_15942309 | 2.76 |
ENST00000544064.1 ENST00000543523.1 ENST00000536793.1 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
chr19_+_16186903 | 2.75 |
ENST00000588507.1 |
TPM4 |
tropomyosin 4 |
chr2_+_241375069 | 2.73 |
ENST00000264039.2 |
GPC1 |
glypican 1 |
chr3_+_105085734 | 2.72 |
ENST00000306107.5 |
ALCAM |
activated leukocyte cell adhesion molecule |
chr13_-_77460525 | 2.71 |
ENST00000377474.2 ENST00000317765.2 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
chr3_+_105086056 | 2.70 |
ENST00000472644.2 |
ALCAM |
activated leukocyte cell adhesion molecule |
chr18_+_47088401 | 2.69 |
ENST00000261292.4 ENST00000427224.2 ENST00000580036.1 |
LIPG |
lipase, endothelial |
chr5_+_76114758 | 2.60 |
ENST00000514165.1 ENST00000296677.4 |
F2RL1 |
coagulation factor II (thrombin) receptor-like 1 |
chr11_+_35198243 | 2.55 |
ENST00000528455.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr17_+_48133459 | 2.55 |
ENST00000320031.8 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
chr4_+_169418255 | 2.55 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr13_-_114567034 | 2.52 |
ENST00000327773.6 ENST00000357389.3 |
GAS6 |
growth arrest-specific 6 |
chr11_+_19799327 | 2.47 |
ENST00000540292.1 |
NAV2 |
neuron navigator 2 |
chr11_+_19798964 | 2.46 |
ENST00000527559.2 |
NAV2 |
neuron navigator 2 |
chr19_+_38755203 | 2.46 |
ENST00000587090.1 ENST00000454580.3 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
chr8_+_22437965 | 2.44 |
ENST00000409141.1 ENST00000265810.4 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chrX_-_154688276 | 2.43 |
ENST00000369445.2 |
F8A3 |
coagulation factor VIII-associated 3 |
chr21_-_27542972 | 2.34 |
ENST00000346798.3 ENST00000439274.2 ENST00000354192.3 ENST00000348990.5 ENST00000357903.3 ENST00000358918.3 ENST00000359726.3 |
APP |
amyloid beta (A4) precursor protein |
chr19_+_38755042 | 2.32 |
ENST00000301244.7 |
SPINT2 |
serine peptidase inhibitor, Kunitz type, 2 |
chr7_-_151511911 | 2.30 |
ENST00000392801.2 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr1_+_182992545 | 2.25 |
ENST00000258341.4 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
chr5_+_102201687 | 2.24 |
ENST00000304400.7 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr2_-_37899323 | 2.24 |
ENST00000295324.3 ENST00000457889.1 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
chr5_+_102201430 | 2.24 |
ENST00000438793.3 ENST00000346918.2 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
chr17_-_1619535 | 2.22 |
ENST00000573075.1 ENST00000574306.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr6_+_36646435 | 2.17 |
ENST00000244741.5 ENST00000405375.1 ENST00000373711.2 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
chr8_+_104311059 | 2.14 |
ENST00000358755.4 ENST00000523739.1 ENST00000540287.1 |
FZD6 |
frizzled family receptor 6 |
chr6_+_7541808 | 2.14 |
ENST00000379802.3 |
DSP |
desmoplakin |
chr2_-_161264385 | 2.12 |
ENST00000409972.1 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr17_-_1619491 | 2.09 |
ENST00000570416.1 ENST00000575626.1 ENST00000610106.1 ENST00000608198.1 ENST00000609442.1 ENST00000334146.3 ENST00000576489.1 ENST00000608245.1 ENST00000609398.1 ENST00000608913.1 ENST00000574016.1 ENST00000571091.1 ENST00000573127.1 ENST00000609990.1 ENST00000576749.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr11_+_35198118 | 2.08 |
ENST00000525211.1 ENST00000526000.1 ENST00000279452.6 ENST00000527889.1 |
CD44 |
CD44 molecule (Indian blood group) |
chr6_+_7541845 | 2.08 |
ENST00000418664.2 |
DSP |
desmoplakin |
chr12_-_50677255 | 2.08 |
ENST00000551691.1 ENST00000394943.3 ENST00000341247.4 |
LIMA1 |
LIM domain and actin binding 1 |
chr15_+_32933866 | 2.05 |
ENST00000300175.4 ENST00000413748.2 ENST00000494364.1 ENST00000497208.1 |
SCG5 |
secretogranin V (7B2 protein) |
chr4_+_88928777 | 2.03 |
ENST00000237596.2 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
chrX_+_154114635 | 2.03 |
ENST00000369446.2 |
F8A1 |
coagulation factor VIII-associated 1 |
chr13_-_52980263 | 2.01 |
ENST00000258613.4 ENST00000544466.1 |
THSD1 |
thrombospondin, type I, domain containing 1 |
chr2_+_173292280 | 2.00 |
ENST00000264107.7 |
ITGA6 |
integrin, alpha 6 |
chr11_+_69455855 | 1.99 |
ENST00000227507.2 ENST00000536559.1 |
CCND1 |
cyclin D1 |
chr3_-_49170405 | 1.98 |
ENST00000305544.4 ENST00000494831.1 |
LAMB2 |
laminin, beta 2 (laminin S) |
chr3_-_16555150 | 1.95 |
ENST00000334133.4 |
RFTN1 |
raftlin, lipid raft linker 1 |
chr5_+_34656569 | 1.92 |
ENST00000428746.2 |
RAI14 |
retinoic acid induced 14 |
chr22_+_31489344 | 1.92 |
ENST00000404574.1 |
SMTN |
smoothelin |
chr15_-_48937982 | 1.90 |
ENST00000316623.5 |
FBN1 |
fibrillin 1 |
chr20_+_44441304 | 1.88 |
ENST00000352551.5 |
UBE2C |
ubiquitin-conjugating enzyme E2C |
chr2_+_173292301 | 1.88 |
ENST00000264106.6 ENST00000375221.2 ENST00000343713.4 |
ITGA6 |
integrin, alpha 6 |
chr2_+_173292390 | 1.86 |
ENST00000442250.1 ENST00000458358.1 ENST00000409080.1 |
ITGA6 |
integrin, alpha 6 |
chr8_+_22436248 | 1.83 |
ENST00000308354.7 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
chr7_-_2883928 | 1.82 |
ENST00000275364.3 |
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
chr20_+_44441215 | 1.82 |
ENST00000356455.4 ENST00000405520.1 |
UBE2C |
ubiquitin-conjugating enzyme E2C |
chr9_-_117880477 | 1.81 |
ENST00000534839.1 ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC |
tenascin C |
chr16_+_29831715 | 1.81 |
ENST00000563915.1 ENST00000357402.5 |
MVP |
major vault protein |
chr21_-_27543425 | 1.80 |
ENST00000448388.2 |
APP |
amyloid beta (A4) precursor protein |
chr10_-_93392811 | 1.79 |
ENST00000238994.5 |
PPP1R3C |
protein phosphatase 1, regulatory subunit 3C |
chr2_-_106054952 | 1.78 |
ENST00000336660.5 ENST00000393352.3 ENST00000607522.1 |
FHL2 |
four and a half LIM domains 2 |
chr5_-_94620239 | 1.73 |
ENST00000515393.1 |
MCTP1 |
multiple C2 domains, transmembrane 1 |
chr14_+_105331596 | 1.73 |
ENST00000556508.1 ENST00000414716.3 ENST00000453495.1 ENST00000418279.1 |
CEP170B |
centrosomal protein 170B |
chr11_+_131781290 | 1.65 |
ENST00000425719.2 ENST00000374784.1 |
NTM |
neurotrimin |
chr6_+_110012462 | 1.62 |
ENST00000441478.2 ENST00000230124.3 |
FIG4 |
FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
chr5_+_140868717 | 1.59 |
ENST00000252087.1 |
PCDHGC5 |
protocadherin gamma subfamily C, 5 |
chr1_-_17304771 | 1.59 |
ENST00000375534.3 |
MFAP2 |
microfibrillar-associated protein 2 |
chr22_-_36236623 | 1.58 |
ENST00000405409.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr17_-_39968406 | 1.57 |
ENST00000393928.1 |
LEPREL4 |
leprecan-like 4 |
chrX_-_51239425 | 1.57 |
ENST00000375992.3 |
NUDT11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr22_-_43042968 | 1.57 |
ENST00000407623.3 ENST00000396303.3 ENST00000438270.1 |
CYB5R3 |
cytochrome b5 reductase 3 |
chr18_-_71959159 | 1.56 |
ENST00000494131.2 ENST00000397914.4 ENST00000340533.4 |
CYB5A |
cytochrome b5 type A (microsomal) |
chr11_+_32112431 | 1.51 |
ENST00000054950.3 |
RCN1 |
reticulocalbin 1, EF-hand calcium binding domain |
chr14_+_90863327 | 1.50 |
ENST00000356978.4 |
CALM1 |
calmodulin 1 (phosphorylase kinase, delta) |
chr11_-_65667997 | 1.49 |
ENST00000312562.2 ENST00000534222.1 |
FOSL1 |
FOS-like antigen 1 |
chr14_+_75746340 | 1.47 |
ENST00000555686.1 ENST00000555672.1 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
chr2_+_71295733 | 1.47 |
ENST00000443938.2 ENST00000244204.6 |
NAGK |
N-acetylglucosamine kinase |
chr1_-_95007193 | 1.45 |
ENST00000370207.4 ENST00000334047.7 |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
chr22_-_36236265 | 1.44 |
ENST00000414461.2 ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr8_-_145018905 | 1.43 |
ENST00000398774.2 |
PLEC |
plectin |
chr16_-_4987065 | 1.42 |
ENST00000590782.2 ENST00000345988.2 |
PPL |
periplakin |
chr5_-_54281491 | 1.37 |
ENST00000381405.4 |
ESM1 |
endothelial cell-specific molecule 1 |
chr17_-_39968855 | 1.35 |
ENST00000355468.3 ENST00000590496.1 |
LEPREL4 |
leprecan-like 4 |
chr17_+_32582293 | 1.35 |
ENST00000580907.1 ENST00000225831.4 |
CCL2 |
chemokine (C-C motif) ligand 2 |
chr8_+_32405785 | 1.34 |
ENST00000287842.3 |
NRG1 |
neuregulin 1 |
chr6_-_31697255 | 1.32 |
ENST00000436437.1 |
DDAH2 |
dimethylarginine dimethylaminohydrolase 2 |
chr16_+_66400533 | 1.32 |
ENST00000341529.3 |
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
chr1_+_150245099 | 1.32 |
ENST00000369099.3 |
C1orf54 |
chromosome 1 open reading frame 54 |
chr16_-_53537105 | 1.31 |
ENST00000568596.1 ENST00000570004.1 ENST00000564497.1 ENST00000300245.4 ENST00000394657.7 |
AKTIP |
AKT interacting protein |
chr2_-_133427767 | 1.29 |
ENST00000397463.2 |
LYPD1 |
LY6/PLAUR domain containing 1 |
chr19_+_5904866 | 1.29 |
ENST00000339485.3 |
VMAC |
vimentin-type intermediate filament associated coiled-coil protein |
chr21_-_45079341 | 1.28 |
ENST00000443485.1 ENST00000291560.2 |
HSF2BP |
heat shock transcription factor 2 binding protein |
chr12_+_108908962 | 1.27 |
ENST00000552695.1 ENST00000552758.1 ENST00000361549.2 |
FICD |
FIC domain containing |
chr13_+_76334795 | 1.27 |
ENST00000526202.1 ENST00000465261.2 |
LMO7 |
LIM domain 7 |
chr8_+_32405728 | 1.27 |
ENST00000523079.1 ENST00000338921.4 ENST00000356819.4 ENST00000287845.5 ENST00000341377.5 |
NRG1 |
neuregulin 1 |
chr4_+_166248775 | 1.26 |
ENST00000261507.6 ENST00000507013.1 ENST00000393766.2 ENST00000504317.1 |
MSMO1 |
methylsterol monooxygenase 1 |
chr11_-_65667884 | 1.26 |
ENST00000448083.2 ENST00000531493.1 ENST00000532401.1 |
FOSL1 |
FOS-like antigen 1 |
chr7_-_151329416 | 1.25 |
ENST00000418337.2 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr4_-_186456766 | 1.25 |
ENST00000284771.6 |
PDLIM3 |
PDZ and LIM domain 3 |
chr14_+_75746781 | 1.23 |
ENST00000555347.1 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
chr15_-_63674218 | 1.23 |
ENST00000178638.3 |
CA12 |
carbonic anhydrase XII |
chr3_-_111314230 | 1.22 |
ENST00000317012.4 |
ZBED2 |
zinc finger, BED-type containing 2 |
chr4_-_186456652 | 1.22 |
ENST00000284767.5 ENST00000284770.5 |
PDLIM3 |
PDZ and LIM domain 3 |
chr11_+_57520715 | 1.21 |
ENST00000524630.1 ENST00000529919.1 ENST00000399039.4 ENST00000533189.1 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
chr1_+_60280458 | 1.21 |
ENST00000455990.1 ENST00000371208.3 |
HOOK1 |
hook microtubule-tethering protein 1 |
chr7_-_27169801 | 1.19 |
ENST00000511914.1 |
HOXA4 |
homeobox A4 |
chr15_-_63674034 | 1.19 |
ENST00000344366.3 ENST00000422263.2 |
CA12 |
carbonic anhydrase XII |
chr2_+_202899310 | 1.19 |
ENST00000286201.1 |
FZD7 |
frizzled family receptor 7 |
chr8_-_93029865 | 1.18 |
ENST00000422361.2 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr2_+_238395879 | 1.18 |
ENST00000445024.2 ENST00000338530.4 ENST00000409373.1 |
MLPH |
melanophilin |
chr13_+_76334567 | 1.18 |
ENST00000321797.8 |
LMO7 |
LIM domain 7 |
chr5_+_148737562 | 1.16 |
ENST00000274569.4 |
PCYOX1L |
prenylcysteine oxidase 1 like |
chr17_-_39674668 | 1.16 |
ENST00000393981.3 |
KRT15 |
keratin 15 |
chr2_+_238395803 | 1.15 |
ENST00000264605.3 |
MLPH |
melanophilin |
chr6_-_75994536 | 1.14 |
ENST00000475111.2 ENST00000230461.6 |
TMEM30A |
transmembrane protein 30A |
chr16_+_68678739 | 1.14 |
ENST00000264012.4 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr9_+_35792151 | 1.14 |
ENST00000342694.2 |
NPR2 |
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
chr9_-_35115836 | 1.14 |
ENST00000378566.1 ENST00000378554.2 ENST00000322813.5 |
FAM214B |
family with sequence similarity 214, member B |
chr17_-_78450398 | 1.13 |
ENST00000306773.4 |
NPTX1 |
neuronal pentraxin I |
chr12_+_26274917 | 1.13 |
ENST00000538142.1 |
SSPN |
sarcospan |
chr22_+_31488433 | 1.11 |
ENST00000455608.1 |
SMTN |
smoothelin |
chr1_+_186798073 | 1.09 |
ENST00000367466.3 ENST00000442353.2 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr6_-_30712313 | 1.09 |
ENST00000376377.2 ENST00000259874.5 |
IER3 |
immediate early response 3 |
chr1_-_163172625 | 1.06 |
ENST00000527988.1 ENST00000531476.1 ENST00000530507.1 |
RGS5 |
regulator of G-protein signaling 5 |
chr16_+_68679193 | 1.06 |
ENST00000581171.1 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr16_+_68678892 | 1.06 |
ENST00000429102.2 |
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
chr15_+_83776137 | 1.06 |
ENST00000322019.9 |
TM6SF1 |
transmembrane 6 superfamily member 1 |
chr2_+_71295717 | 1.05 |
ENST00000418807.3 ENST00000443872.2 |
NAGK |
N-acetylglucosamine kinase |
chr11_-_66084508 | 1.05 |
ENST00000311330.3 |
CD248 |
CD248 molecule, endosialin |
chr19_+_41725140 | 1.04 |
ENST00000359092.3 |
AXL |
AXL receptor tyrosine kinase |
chr2_+_37571717 | 1.04 |
ENST00000338415.3 ENST00000404976.1 |
QPCT |
glutaminyl-peptide cyclotransferase |
chr17_-_76899275 | 1.04 |
ENST00000322630.2 ENST00000586713.1 |
DDC8 |
Protein DDC8 homolog |
chr17_+_28705921 | 1.04 |
ENST00000225719.4 |
CPD |
carboxypeptidase D |
chr17_+_39411636 | 1.04 |
ENST00000394008.1 |
KRTAP9-9 |
keratin associated protein 9-9 |
chr21_-_39870339 | 1.03 |
ENST00000429727.2 ENST00000398905.1 ENST00000398907.1 ENST00000453032.2 ENST00000288319.7 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr12_-_110434021 | 1.03 |
ENST00000355312.3 ENST00000551209.1 ENST00000550186.1 |
GIT2 |
G protein-coupled receptor kinase interacting ArfGAP 2 |
chr2_+_37571845 | 1.02 |
ENST00000537448.1 |
QPCT |
glutaminyl-peptide cyclotransferase |
chr4_-_120550146 | 1.02 |
ENST00000354960.3 |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
chr3_+_49507559 | 1.01 |
ENST00000421560.1 ENST00000308775.2 ENST00000545947.1 ENST00000541308.1 ENST00000539901.1 ENST00000538711.1 ENST00000418588.1 |
DAG1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
chr3_-_87040233 | 1.01 |
ENST00000398399.2 |
VGLL3 |
vestigial like 3 (Drosophila) |
chr12_+_27485785 | 1.01 |
ENST00000544915.1 |
ARNTL2 |
aryl hydrocarbon receptor nuclear translocator-like 2 |
chr7_-_27170352 | 1.00 |
ENST00000428284.2 ENST00000360046.5 |
HOXA4 |
homeobox A4 |
chr11_+_67070919 | 1.00 |
ENST00000308127.4 ENST00000308298.7 |
SSH3 |
slingshot protein phosphatase 3 |
chr19_+_18794470 | 1.00 |
ENST00000321949.8 ENST00000338797.6 |
CRTC1 |
CREB regulated transcription coactivator 1 |
chr1_-_59043166 | 1.00 |
ENST00000371225.2 |
TACSTD2 |
tumor-associated calcium signal transducer 2 |
chr11_-_86383650 | 0.99 |
ENST00000526944.1 ENST00000530335.1 ENST00000543262.1 ENST00000524826.1 |
ME3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr20_+_17550691 | 0.99 |
ENST00000474024.1 |
DSTN |
destrin (actin depolymerizing factor) |
chr11_+_67776012 | 0.98 |
ENST00000539229.1 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
chr15_+_83776324 | 0.96 |
ENST00000379390.6 ENST00000379386.4 ENST00000565774.1 ENST00000565982.1 |
TM6SF1 |
transmembrane 6 superfamily member 1 |
chr3_-_52002403 | 0.96 |
ENST00000490063.1 ENST00000468324.1 ENST00000497653.1 ENST00000484633.1 |
PCBP4 |
poly(rC) binding protein 4 |
chr8_+_98881268 | 0.95 |
ENST00000254898.5 ENST00000524308.1 ENST00000522025.2 |
MATN2 |
matrilin 2 |
chr14_+_105781102 | 0.95 |
ENST00000547217.1 |
PACS2 |
phosphofurin acidic cluster sorting protein 2 |
chr20_-_23030296 | 0.94 |
ENST00000377103.2 |
THBD |
thrombomodulin |
chr16_-_29517141 | 0.93 |
ENST00000550665.1 |
RP11-231C14.4 |
Uncharacterized protein |
chr20_+_62697564 | 0.92 |
ENST00000458442.1 |
TCEA2 |
transcription elongation factor A (SII), 2 |
chrX_-_107019181 | 0.91 |
ENST00000315660.4 ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3 |
TSC22 domain family, member 3 |
chr14_+_69658194 | 0.91 |
ENST00000409018.3 ENST00000409014.1 ENST00000409675.1 |
EXD2 |
exonuclease 3'-5' domain containing 2 |
chr16_-_18468926 | 0.90 |
ENST00000545114.1 |
RP11-1212A22.4 |
LOC339047 protein; Nuclear pore complex-interacting protein family member A3; Nuclear pore complex-interacting protein family member A5; Protein PKD1P1 |
chr1_+_25071848 | 0.89 |
ENST00000374379.4 |
CLIC4 |
chloride intracellular channel 4 |
chr1_+_120254510 | 0.89 |
ENST00000369409.4 |
PHGDH |
phosphoglycerate dehydrogenase |
chr19_-_44174305 | 0.88 |
ENST00000601723.1 ENST00000339082.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr2_-_136288113 | 0.87 |
ENST00000401392.1 |
ZRANB3 |
zinc finger, RAN-binding domain containing 3 |
chr11_-_61646054 | 0.87 |
ENST00000527379.1 |
FADS3 |
fatty acid desaturase 3 |
chr6_-_80657292 | 0.87 |
ENST00000369816.4 |
ELOVL4 |
ELOVL fatty acid elongase 4 |
chr3_-_50360192 | 0.87 |
ENST00000442581.1 ENST00000447092.1 ENST00000357750.4 |
HYAL2 |
hyaluronoglucosaminidase 2 |
chr5_-_172662303 | 0.86 |
ENST00000517440.1 ENST00000329198.4 |
NKX2-5 |
NK2 homeobox 5 |
chr16_-_74640986 | 0.86 |
ENST00000422840.2 ENST00000565260.1 ENST00000447066.2 ENST00000205061.5 |
GLG1 |
golgi glycoprotein 1 |
chr15_+_68924327 | 0.86 |
ENST00000543950.1 |
CORO2B |
coronin, actin binding protein, 2B |
chr11_+_67071050 | 0.85 |
ENST00000376757.5 |
SSH3 |
slingshot protein phosphatase 3 |
chr5_+_138089100 | 0.85 |
ENST00000520339.1 ENST00000355078.5 ENST00000302763.7 ENST00000518910.1 |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr3_-_158450475 | 0.84 |
ENST00000237696.5 |
RARRES1 |
retinoic acid receptor responder (tazarotene induced) 1 |
chr12_-_27167233 | 0.84 |
ENST00000535819.1 ENST00000543803.1 ENST00000535423.1 ENST00000539741.1 ENST00000343028.4 ENST00000545600.1 ENST00000543088.1 |
TM7SF3 |
transmembrane 7 superfamily member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 18.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 6.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 5.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 12.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 7.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 5.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 2.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 4.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 6.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 3.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 3.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 6.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 3.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 2.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 2.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 1.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 15.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 10.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 11.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 12.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 3.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 7.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 5.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 8.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 9.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 7.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 3.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 7.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 4.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
1.1 | 15.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.1 | 4.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.9 | 2.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 2.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.8 | 3.2 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 2.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.7 | 4.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.6 | 6.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 4.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.4 | 2.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 4.4 | GO:0033643 | host cell part(GO:0033643) |
0.3 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 1.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 3.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 5.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 2.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 4.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 7.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 0.8 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.2 | 0.8 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 2.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 5.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 0.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 3.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 7.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 4.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 9.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 2.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 2.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 0.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 6.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 4.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 4.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 7.7 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 6.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 1.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 6.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 1.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 2.4 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 2.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.7 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 1.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0001673 | nuclear nucleosome(GO:0000788) male germ cell nucleus(GO:0001673) |
0.0 | 1.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 2.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 2.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 4.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 5.6 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.0 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
2.6 | 10.5 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
2.1 | 4.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
1.6 | 4.7 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.5 | 5.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.2 | 6.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.8 | 2.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.7 | 2.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.7 | 2.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.6 | 1.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.5 | 4.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 2.0 | GO:0048763 | HLH domain binding(GO:0043398) calcium-induced calcium release activity(GO:0048763) |
0.4 | 1.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 1.6 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.4 | 5.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 3.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 1.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.3 | 2.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 7.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 3.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 3.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.6 | GO:0052840 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.3 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 2.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.3 | 2.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 1.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.7 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.2 | 0.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.2 | 0.9 | GO:0033906 | protein tyrosine kinase inhibitor activity(GO:0030292) hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.6 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 0.4 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 1.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 14.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 8.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.7 | GO:0047708 | biotinidase activity(GO:0047708) |
0.2 | 2.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 4.5 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 1.0 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 7.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.8 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 4.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.9 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 2.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 0.8 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 2.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.6 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 2.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.9 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.4 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 3.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.2 | GO:0032427 | GBD domain binding(GO:0032427) |
0.1 | 0.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 3.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 2.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.8 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 7.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 7.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 2.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 1.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.0 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 2.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 1.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) 5.8S rRNA binding(GO:1990932) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.5 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 2.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 1.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 2.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 2.8 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.0 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.0 | 0.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 3.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.8 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 1.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
2.6 | 10.5 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
1.3 | 5.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 5.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.2 | 4.9 | GO:0021564 | vagus nerve development(GO:0021564) |
1.1 | 3.3 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
1.1 | 1.1 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.9 | 10.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.9 | 4.5 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.9 | 5.2 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.8 | 5.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.8 | 4.9 | GO:2000669 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.8 | 4.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.7 | 7.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.7 | 2.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 2.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.7 | 2.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.7 | 4.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 5.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 2.5 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.6 | 4.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 1.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 2.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.5 | 7.6 | GO:0035878 | nail development(GO:0035878) |
0.5 | 2.6 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.5 | 15.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.5 | 0.5 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.5 | 3.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 1.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.5 | 1.4 | GO:0048627 | myoblast development(GO:0048627) |
0.5 | 0.5 | GO:0010157 | response to chlorate(GO:0010157) |
0.5 | 3.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) positive regulation of exit from mitosis(GO:0031536) |
0.5 | 5.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 2.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 1.3 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.4 | 2.2 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.4 | 0.9 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.4 | 2.2 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.4 | 1.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.4 | 2.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.4 | 2.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.4 | 6.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 2.6 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.3 | 2.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 1.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.3 | 1.6 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.3 | 1.5 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.9 | GO:0021678 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
0.3 | 2.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.3 | 0.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 0.8 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.3 | 1.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 0.8 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 5.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 3.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.7 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.2 | 1.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 3.8 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.7 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 2.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.7 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.2 | 2.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 1.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.2 | 0.8 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.2 | 0.2 | GO:0033087 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 1.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.6 | GO:2000360 | positive regulation of female gonad development(GO:2000196) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.2 | 4.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 1.0 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.2 | 1.9 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 1.1 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.2 | 0.6 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 3.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.2 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.7 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.2 | 0.5 | GO:1990535 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
0.2 | 1.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 1.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 3.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 1.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 2.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.2 | 0.5 | GO:1905066 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) blood vessel lumenization(GO:0072554) blood vessel endothelial cell fate specification(GO:0097101) positive regulation of ephrin receptor signaling pathway(GO:1901189) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.9 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.6 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 1.4 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.8 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 1.8 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.1 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
0.1 | 0.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.1 | 2.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
0.1 | 0.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.1 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 1.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 1.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.7 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 3.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.1 | 0.3 | GO:1900368 | transcription, RNA-templated(GO:0001172) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 2.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 0.5 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 2.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 1.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.7 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.6 | GO:0051503 | ADP transport(GO:0015866) ATP transport(GO:0015867) adenine nucleotide transport(GO:0051503) |
0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.1 | 3.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.2 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 1.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 2.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.8 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 3.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 2.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 2.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 1.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.9 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:2001303 | cellular response to interleukin-13(GO:0035963) lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.0 | 0.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 1.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.4 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.1 | GO:2000213 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.0 | 0.3 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 1.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.1 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.0 | 2.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:2000110 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 1.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
0.0 | 0.1 | GO:1902004 | regulation of beta-amyloid formation(GO:1902003) positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.5 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.7 | GO:0048511 | rhythmic process(GO:0048511) |
0.0 | 0.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.0 | 0.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.6 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 1.6 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.2 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.9 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.0 | 8.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.3 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.0 | 0.7 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 1.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.4 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |